IP Group Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

IP Group hat ein Gesamteigenkapital von £1.1B und eine Gesamtverschuldung von £152.0M, was einen Verschuldungsgrad von 14.2% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen £1.3B bzw. £214.7M.

Wichtige Informationen

14.2%

Verhältnis von Schulden zu Eigenkapital

UK£152.00m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	UK£161.30m
Eigenkapital	UK£1.07b
Gesamtverbindlichkeiten	UK£214.70m
Gesamtvermögen	UK£1.29b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: IPOLDie kurzfristigen Aktiva des Unternehmens (£207.8M) übersteigen seine kurzfristigen Passiva (£22.4M).

Langfristige Verbindlichkeiten: IPOLDie kurzfristigen Vermögenswerte des Unternehmens (£207.8M) übersteigen seine langfristigen Verbindlichkeiten (£192.3M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: IPOL über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: IPOLDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 9.9% auf 14.2% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: IPOL auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als 3 Jahre verfügt.

Vorhersage Cash Runway: IPOL über eine ausreichende Liquiditätsreserve für mehr als 3 Jahre verfügt, wenn der freie Cashflow weiterhin mit historischen Raten von 10% pro Jahr wächst

IP Group Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024

Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO).

CEO & Executive Director recently sold UK£98k worth of stock

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

IP Group Plc, Annual General Meeting, Jun 12, 2024

New minor risk - Financial data availability

IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024

IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023.

First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022)

Now 21% undervalued

IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023

Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021)

IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023

Scaleworks Inc. acquired Import.io Ltd.

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Now 21% undervalued

Insufficient new directors

Insufficient new directors

Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed

First half 2022 earnings released

IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022

IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022

IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022

Insider recently bought UK£61k worth of stock

Executive Officer recently bought UK£50k worth of stock

Investor sentiment improved over the past week

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020)

NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.

IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited.

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Revenue beats expectations

IP Group Plc, Annual General Meeting, Jun 09, 2021

IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021

Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO).

New 90-day high: UK£1.11

New 90-day high: UK£0.98

New 90-day high: UK£0.91

Integumen Plc (AIM:SKIN) reached an agreement to acquire Modern Water plc (AIM:MWG) from a group of sellers for £21.3 million.

An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO).

Hitachi Rail Limited agreed to acquire Perpetuum Ltd.

IP Group Plc to Report First Half, 2020 Results on Aug 05, 2020

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen